版本:
中国

BRIEF-Aveo Pharmaceuticals says Eusa Pharma submits its responses to EMA day 120 list of questions

Nov 28 Aveo Pharmaceuticals Inc -

* Says its development partner, Eusa Pharma, submitted its responses to European Medicines Agency (EMA) day 120 list of questions

* Next step in filing process, EMA day 180 list of outstanding issues, is expected in Q1 of 2017. Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐